Larry D Anderson

48PUBLICATIONS

182CO-AUTHORS

Predictive and prognostic markersHaematological tumoursMedical physicsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (48)

Sort by Publication Date:

|Jul 03, 2026

Idecabtagene vicleucel and endogenous T-cell phenotypes linked to progression-free survival in relapsed multiple myeloma.

|Jul 02, 2026

Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

|Jun 03, 2026

Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma.

|May 01, 2026

How I Treat Plasma Cell Leukemia.

|Apr 14, 2026

Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Mar 28, 2026

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

Pageof 8

Frequent Collaborators

20 joint publications

Surbhi Sidana

19 joint publications

Krina Patel

16 joint publications

Douglas W Sborov

16 joint publications

Rahul Banerjee

16 joint publications

Peter Voorhees

16 joint publications

James A Davis

15 joint publications

Jack Khouri

14 joint publications

Doris K Hansen

14 joint publications

Gurbakhash Kaur

12 joint publications

Aimaz Afrough

Frequent Collaborators

20 joint publications

Surbhi Sidana

19 joint publications

Krina Patel

16 joint publications

Douglas W Sborov

16 joint publications

Rahul Banerjee